WCM
IDXX icon

Weaver Capital Management’s Idexx Laboratories IDXX Stock Holding History

Weaver Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Hold
600
– – 0.07% 131
2026
Q1 		$337K Sell
600
-31
-5% -$19.9K 0.07% 133
2025
Q4 		$427K Sell
631
-3
-0.5% -$2.04K 0.09% 136
2025
Q3 		$405K Sell
634
-7
-1% -$4.25K 0.09% 132
2025
Q2 		$344K Hold
641
– – 0.08% 142
2025
Q1 		$269K Buy
641
+9
+1% +$3.91K 0.07% 151
2024
Q4 		$261K Buy
+632
New +$277K 0.07% 153
2024
Q2 		– Sell
-644
Closed -$348K – 179
2024
Q1 		$348K Buy
+644
New +$352K 0.12% 124

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Weaver Capital Management's IDXX Position: Q2 2026 in Review

Weaver Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 600 shares worth $337K. The position accounts for 0.07% of the portfolio, ranked #131.

Weaver Capital Management first reported a position in IDXX in Q1 2024 and has held it in 8 quarters since. The position peaked at $427K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Weaver Capital Management held 600 shares of Idexx Laboratories worth $337K as of Q2 2026.
  • Weaver Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.07% of Weaver Capital Management's portfolio in Q2 2026, its #131 holding.
  • Weaver Capital Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 8 quarters since.
  • Weaver Capital Management's Idexx Laboratories position peaked at $427K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Weaver Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.